Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 283

1.

Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.

Joosten LA, Lubberts E, Durez P, Helsen MM, Jacobs MJ, Goldman M, van den Berg WB.

Arthritis Rheum. 1997 Feb;40(2):249-60.

PMID:
9041936
2.

Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.

Joosten LA, Helsen MM, van de Loo FA, van den Berg WB.

Arthritis Rheum. 2008 Feb;58(2 Suppl):S110-22. doi: 10.1002/art.23363.

3.
4.

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.

Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.

5.

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.

Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB.

Arthritis Rheum. 2004 Feb;50(2):650-9.

7.

Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.

Van Lent PL, Van De Loo FA, Holthuysen AE, Van Den Bersselaar LA, Vermeer H, Van Den Berg WB.

J Rheumatol. 1995 Dec;22(12):2250-8.

PMID:
8835558
8.

Dual role of IL-12 in early and late stages of murine collagen type II arthritis.

Joosten LA, Lubberts E, Helsen MM, van den Berg WB.

J Immunol. 1997 Oct 15;159(8):4094-102.

PMID:
9379000
9.

Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.

Koenders MI, Marijnissen RJ, Devesa I, Lubberts E, Joosten LA, Roth J, van Lent PL, van de Loo FA, van den Berg WB.

Arthritis Rheum. 2011 Aug;63(8):2329-39. doi: 10.1002/art.30418.

10.

Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.

van den Berg WB, Joosten LA, Helsen M, van de Loo FA.

Clin Exp Immunol. 1994 Feb;95(2):237-43.

11.

Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.

Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, Dunstan C, Kollias G, Steiner G, Smolen J, Schett G.

Arthritis Rheum. 2004 Jan;50(1):277-90.

13.

Interleukin-10 inhibition of the progression of established collagen-induced arthritis.

Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN, Feldmann M.

Arthritis Rheum. 1996 Mar;39(3):495-503.

PMID:
8607899
14.

Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis.

Kuiper S, Joosten LA, Bendele AM, Edwards CK 3rd, Arntz OJ, Helsen MM, Van de Loo FA, Van den Berg WB.

Cytokine. 1998 Sep;10(9):690-702.

PMID:
9770330
15.

Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.

Gabay C, Marinova-Mutafchieva L, Williams RO, Gigley JP, Butler DM, Feldmann M, Arend WP.

Arthritis Rheum. 2001 Feb;44(2):451-62.

16.

Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee.

Bakker AC, Joosten LA, Arntz OJ, Helsen MM, Bendele AM, van de Loo FA, van den Berg WB.

Arthritis Rheum. 1997 May;40(5):893-900.

PMID:
9153551
17.

Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis.

Smeets RL, van de Loo FA, Joosten LA, Arntz OJ, Bennink MB, Loesberg WA, Dmitriev IP, Curiel DT, Martin MU, van den Berg WB.

Arthritis Rheum. 2003 Oct;48(10):2949-58.

19.

Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein.

Mindrescu C, Thorbecke GJ, Klein MJ, Vilcek J, Wisniewski HG.

Arthritis Rheum. 2000 Dec;43(12):2668-77.

20.

Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1beta and IL-6 production in autoimmune arthritis.

Lee JH, Cho ML, Kim JI, Moon YM, Oh HJ, Kim GT, Ryu S, Baek SH, Lee SH, Kim HY, Kim SI.

J Rheumatol. 2009 Apr;36(4):684-92. doi: 10.3899/jrheum.080169. Epub 2009 Feb 17. Erratum in: J Rheumatol. 2009 May;36(5):1091.

PMID:
19228664

Supplemental Content

Support Center